In the News
Seeking Early Answers to Formulation Questions
Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.
Patient Stories Can Bridge the Gap Between Pharma and Patients
Patients are sharing their stories in an effort to educate other stakeholders, and the pharma industry is using that knowledge sharing to improve on messaging and patient interaction.
Patient-Enhanced Drug Discovery and Development
Patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation.
Bringing the Patient Voice into Clinical Trials
In an effort to put patients at the center, pharmaceutical companies are starting to gather input from patients earlier in the clinical trial process.
PPD prices IPO, seeking $1.5bn at a $9bn valuation
PPD sets terms of planned initial public offering.
PPD begins trading on Nasdaq
PPD announces the pricing of its initial public offering of 60 million shares of its common stock at $27.00 per share.
Wilmington pharmaceutical company PPD goes public
Shares of PPD’s common stock begin trading on The Nasdaq Global Select Market under the symbol “PPD.”
China’s evolving regulatory environment: Special report
Alistair Davidson, Guoliang Liu and Bill Wang assess how the clinical trial market has responded over the past few years and analyze the future of the China market.
PPD files for IPO
PPD announces the launch of its initial public offering of 60 million shares of its common stock.
